Trial
NCT04412772
Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Queen's Medical Center
Collaborators
—
Condition
COVID-19
Intervention
Tocilizumab
Why stopped
Per Queen's Regulatory Office, study is terminated or expired.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-10